SE505213C2 - Dideoxikarbocykliska nukleosidanaloger, farmaceutiska beredningar därav samt mellanprodukter - Google Patents

Dideoxikarbocykliska nukleosidanaloger, farmaceutiska beredningar därav samt mellanprodukter

Info

Publication number
SE505213C2
SE505213C2 SE8900192A SE8900192A SE505213C2 SE 505213 C2 SE505213 C2 SE 505213C2 SE 8900192 A SE8900192 A SE 8900192A SE 8900192 A SE8900192 A SE 8900192A SE 505213 C2 SE505213 C2 SE 505213C2
Authority
SE
Sweden
Prior art keywords
compound
formula
pharmaceutically acceptable
compounds
purin
Prior art date
Application number
SE8900192A
Other languages
English (en)
Swedish (sv)
Other versions
SE8900192D0 (sv
SE8900192L (sv
Inventor
Robert Vince
Mei Hua
Peter Leslie Myers
Richard Storer
Original Assignee
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/146,252 external-priority patent/US4916224A/en
Priority claimed from GB888821011A external-priority patent/GB8821011D0/en
Priority claimed from US07/278,652 external-priority patent/US4931559A/en
Application filed by Univ Minnesota filed Critical Univ Minnesota
Publication of SE8900192D0 publication Critical patent/SE8900192D0/xx
Publication of SE8900192L publication Critical patent/SE8900192L/xx
Publication of SE505213C2 publication Critical patent/SE505213C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SE8900192A 1988-01-20 1989-01-19 Dideoxikarbocykliska nukleosidanaloger, farmaceutiska beredningar därav samt mellanprodukter SE505213C2 (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/146,252 US4916224A (en) 1988-01-20 1988-01-20 Dideoxycarbocyclic nucleosides
GB888821011A GB8821011D0 (en) 1988-09-07 1988-09-07 Chemical compounds
US07/278,652 US4931559A (en) 1988-01-20 1988-12-05 Optically-active isomers of dideoxycarbocyclic nucleosides

Publications (3)

Publication Number Publication Date
SE8900192D0 SE8900192D0 (sv) 1989-01-19
SE8900192L SE8900192L (sv) 1989-07-21
SE505213C2 true SE505213C2 (sv) 1997-07-14

Family

ID=27264063

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8900192A SE505213C2 (sv) 1988-01-20 1989-01-19 Dideoxikarbocykliska nukleosidanaloger, farmaceutiska beredningar därav samt mellanprodukter

Country Status (29)

Country Link
JP (1) JP2793825B2 (da)
KR (1) KR0127137B1 (da)
AT (1) AT397801B (da)
AU (2) AU626278B2 (da)
BE (1) BE1003815A4 (da)
CA (1) CA1339896C (da)
CH (1) CH679152A5 (da)
DE (1) DE3901502C2 (da)
DK (1) DK175131B1 (da)
ES (1) ES2010091A6 (da)
FI (1) FI93546C (da)
FR (1) FR2626002B1 (da)
GB (1) GB2217320B (da)
GR (1) GR890100033A (da)
HU (1) HU203755B (da)
IE (1) IE62275B1 (da)
IL (1) IL88999A (da)
IT (1) IT1229531B (da)
LU (1) LU87437A1 (da)
MY (1) MY103801A (da)
NL (1) NL8900122A (da)
NO (1) NO169123C (da)
NZ (1) NZ227663A (da)
OA (1) OA09031A (da)
PL (1) PL163814B1 (da)
PT (1) PT89482B (da)
RU (1) RU2114846C1 (da)
SE (1) SE505213C2 (da)
YU (1) YU47791B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1215339B (it) * 1987-01-14 1990-02-08 Co Pharma Corp Srl Procedimento per la preparazione di 9-(idrossialchil)-ipoxantine
US5631370A (en) 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
US4939252A (en) * 1989-04-20 1990-07-03 Hoffmann-La Roche Inc. Novel intermediates for the preparation of Carbovir
DE69033252T2 (de) * 1989-06-27 1999-12-09 The Wellcome Foundation Ltd., Greenford Therapeutische nukleoside
GB8916477D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916478D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916479D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916480D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
US5144034A (en) * 1990-04-06 1992-09-01 Glaxo Inc. Process for the synthesis of cyclopentene derivatives of purines
US5057630A (en) * 1990-04-06 1991-10-15 Glaxo Inc. Synthesis of cyclopentene derivatives
US5126452A (en) * 1990-04-06 1992-06-30 Glaxo Inc. Synthesis of purine substituted cyclopentene derivatives
US5241069A (en) * 1990-04-06 1993-08-31 Glaxo Inc. Carbonate intermediates for the synthesis of purine substituted cyclopentene derivatives
GB9108376D0 (en) * 1991-04-19 1991-06-05 Enzymatix Ltd Cyclopentenes
HUT74989A (en) * 1993-11-12 1997-03-28 Merrell Pharma Inc 6-oxo-nucleosides useful as immunosuppressants
GB9721780D0 (en) 1997-10-14 1997-12-10 Glaxo Group Ltd Process for the synthesis of chloropurine intermediates
ATE240945T1 (de) * 1998-10-30 2003-06-15 Lonza Ag Verfahren zur herstellung von 4-((2',5'-diamino- 6'-halogenpyrimidin-4'-yl)amino)-cyclopent-2- enylmethanolen
KR100606625B1 (ko) 1998-10-30 2006-07-28 론자 아게 4-[(2',5'-디아미노-6'-할로피리미딘-4'-일)아미노]-시클로펜트-2-에닐메탄올의 제조 방법
TWI229674B (en) 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
GB9903091D0 (en) * 1999-02-12 1999-03-31 Glaxo Group Ltd Therapeutic nucleoside compound
AR039540A1 (es) * 2002-05-13 2005-02-23 Tibotec Pharm Ltd Compuestos microbicidas con contenido de pirimidina o triazina
JP7104154B2 (ja) 2018-07-27 2022-07-20 富士フイルム株式会社 シクロペンテニルプリン誘導体またはその塩
JP2023519882A (ja) 2020-03-27 2023-05-15 ソム、イノベーション、バイオテック、ソシエダッド、アノニマ シヌクレイノパチーの治療に有用な化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268672A (en) * 1977-02-09 1981-05-19 The Regents Of The University Of Minnesota Adenosine deaminase resistant antiviral purine nucleosides and method of preparation
US4742064A (en) * 1985-09-10 1988-05-03 Regents Of The University Of Minnesota Antiviral carbocyclic analogs of xylofuranosylpurines
JPS62177234A (ja) * 1986-01-30 1987-08-04 Mitsubishi Heavy Ind Ltd 遠心紡糸によるカ−ボン繊維の製造装置
IN164556B (da) * 1986-03-06 1989-04-08 Takeda Chemical Industries Ltd
NZ229453A (en) * 1988-06-10 1991-08-27 Univ Minnesota & Southern Rese A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.

Also Published As

Publication number Publication date
HUT48887A (en) 1989-07-28
ES2010091A6 (es) 1989-10-16
DK175131B1 (da) 2004-06-14
GB2217320B (en) 1992-04-08
NO890253D0 (no) 1989-01-19
FI890286A0 (fi) 1989-01-19
GB2217320A (en) 1989-10-25
NZ227663A (en) 1990-09-26
JP2793825B2 (ja) 1998-09-03
GR890100033A (el) 1994-03-31
NO890253L (no) 1989-07-21
RU2114846C1 (ru) 1998-07-10
AU626278B2 (en) 1992-07-30
JPH02196788A (ja) 1990-08-03
AU2867189A (en) 1989-07-20
NO169123B (no) 1992-02-03
AT397801B (de) 1994-07-25
IE62275B1 (en) 1995-01-25
NO169123C (no) 1992-05-13
ATA10689A (de) 1993-11-15
AU637015B2 (en) 1993-05-13
BE1003815A4 (fr) 1992-06-23
MY103801A (en) 1993-09-30
IE890153L (en) 1989-07-20
IL88999A0 (en) 1989-08-15
DE3901502A1 (de) 1989-07-27
FI93546C (fi) 1995-04-25
IT1229531B (it) 1991-09-04
AU1018092A (en) 1992-03-12
PL163814B1 (en) 1994-05-31
DK23489D0 (da) 1989-01-19
KR0127137B1 (ko) 1997-12-29
IL88999A (en) 1994-12-29
YU12389A (en) 1991-10-31
YU47791B (sr) 1996-01-09
KR890011902A (ko) 1989-08-23
FI93546B (fi) 1995-01-13
HU203755B (en) 1991-09-30
DK23489A (da) 1989-07-21
FR2626002A1 (fr) 1989-07-21
GB8901187D0 (en) 1989-03-15
OA09031A (en) 1991-03-31
FI890286A (fi) 1989-07-21
CH679152A5 (da) 1991-12-31
SE8900192D0 (sv) 1989-01-19
FR2626002B1 (fr) 1994-01-28
LU87437A1 (fr) 1989-08-30
IT8947546A0 (it) 1989-01-19
NL8900122A (nl) 1989-08-16
PL277261A1 (en) 1989-09-18
DE3901502C2 (de) 2002-06-13
PT89482A (pt) 1989-10-04
CA1339896C (en) 1998-06-02
PT89482B (pt) 1994-02-28
SE8900192L (sv) 1989-07-21

Similar Documents

Publication Publication Date Title
SE505213C2 (sv) Dideoxikarbocykliska nukleosidanaloger, farmaceutiska beredningar därav samt mellanprodukter
RU2067097C1 (ru) Способ получения дидезоксидидегидрокарбоциклических нуклеозидов
FI111722B (fi) Menetelmä valmistaa cis-4-amino-1-(2-hydroksimetyyli-1,3-oksatiolan-5-yyli)-(1H)-pyrimidin-2-onin (-)-enantiomeeriä käytettäväksi virustenvastaisena aineena
EP0382526B1 (en) Substituted -1,3-oxathiolanes with antiviral properties
DE69031057T2 (de) Nucleosidanaloge
HU211537A9 (en) Therapeutic nucleosides
HUT70030A (en) 1,3-oxathiolane nucleoside analogues and pharmaceutical compositions containing them, and process for their preparation
CZ658390A3 (en) Enantiomeric purine derivatives, process of their preparation, pharmaceutical compositions containing thereof and their use
US5122517A (en) Antiviral combination comprising nucleoside analogs
US4950758A (en) Optically-active isomers of dideoxycarbocyclic nucleosides
AU627188B2 (en) Pharmaceutical products
US4931559A (en) Optically-active isomers of dideoxycarbocyclic nucleosides
HU200461B (en) Process for producing new 9-(n-hyudroxyalkoxy)-purine derivatives and pharmaceutical compositions comprising such compounds
JP3146423B2 (ja) 置換プリン
US10167302B2 (en) Phosphonate nucleosides useful in the treatment of viral diseases
GB2243609A (en) Carbocyclic nucleosides
CN1031055C (zh) 二脱氧二脱氢碳环核苷的制备方法

Legal Events

Date Code Title Description
NUG Patent has lapsed